Milana Čabrilo Lazić
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Milana Čabrilo Lazić has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Miljan Puletic
Faculty of Stomatology, Pancevo, University Business Academy, 26000 Pancevo, Serbia
2 shared publications - Stevan Avramov
Institute for Biological Research “Siniša Stanković”, Belgrade
2 shared publications - Vladimir Biocanin
Faculty of Stomatology in Pančevo, Pancevo, Serbia; University Business Academy in Novi Sad, Novi Sad, Serbia; Faculty of Stomatology, Pancevo, Serbia, Serbia
2 shared publications - Adam Malesevic
University of Business Academy, Faculty of Dentistry, Pančevo, Novi Sad, Serbia
1 shared publication - Branislava Vukovic
University Business Academy in Novi Sad, Faculty of Stomatology, Pančevo, Serbia
1 shared publication - Branislava Vuković
Faculty of Dentistry, Pancevo, University Business Academy 1 , Novi Sad 21000, Serbia
1 shared publication
Latest Publications
- Open Access
- 31 May 2023
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 17 (05) , 643-648
The investigation of antibacterial activity of hyperlight fluid fusion subcellular essential complex
Introduction: This study aimed to investigate the possibility of applying the hyperlight fluid fusion essential complex in dental plaque control, and to evaluate the effectiveness of new and modern agents used for the prevention and early treatment of gingivitis. Methodology: The study included 60 subjects randomly divided into two groups. The control group was assigned to 0.12% chlorhexidine (CHX) mouth rinse, whereas the test group used a solution based on hyper-harmonized hydroxylated fullerene water complex (3HFWC), twice daily for 2 weeks. The plaque, gingivitis and bleeding scores were evaluated and recorded. Collected plaque samples were seeded on blood agar and incubated aerobically at a temperature of 37 °C for 24-48 hours. In order to isolate anaerobic bacteria, samples were seeded on Schaedler Agar and incubated anaerobically at 37 °C for seven days. Serial dilutions in saline from 101 - 106 were made, and grown colonies were counted and identified using the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) system. Results: The reduction in the number of bacteria was significant in both control and test groups. The reduction was greater in the control group compared to the experimental group, but without statistically significant difference. Conclusions: 3HFWC treatment causes significant reduction in the number of dental plaque microorganisms. Since 3HFWC solution exhibited a bacteriostatic effect similar to chlorhexidine it could be an adequate addition to solution of a growing problem in prevention and early treatment of gingivitis and periodontitis.
- 31 May 2023
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 17 (05) , 643-648
Open AccessThe investigation of antibacterial activity of hyperlight fluid fusion subcellular essential complex
Introduction: This study aimed to investigate the possibility of applying the hyperlight fluid fusion essential complex in dental plaque control, and to evaluate the effectiveness of new and modern agents used for the prevention and early treatment of gingivitis. Methodology: The study included 60 subjects randomly divided into two groups. The control group was assigned to 0.12% chlorhexidine (CHX) mouth rinse, whereas the test group used a solution based on hyper-harmonized hydroxylated fullerene water complex (3HFWC), twice daily for 2 weeks. The plaque, gingivitis and bleeding scores were evaluated and recorded. Collected plaque samples were seeded on blood agar and incubated aerobically at a temperature of 37 °C for 24-48 hours. In order to isolate anaerobic bacteria, samples were seeded on Schaedler Agar and incubated anaerobically at 37 °C for seven days. Serial dilutions in saline from 101 - 106 were made, and grown colonies were counted and identified using the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) system. Results: The reduction in the number of bacteria was significant in both control and test groups. The reduction was greater in the control group compared to the experimental group, but without statistically significant difference. Conclusions: 3HFWC treatment causes significant reduction in the number of dental plaque microorganisms. Since 3HFWC solution exhibited a bacteriostatic effect similar to chlorhexidine it could be an adequate addition to solution of a growing problem in prevention and early treatment of gingivitis and periodontitis.
- Open Access
- 26 January 2023
- Published by Laser Institute of America in Journal of Laser Applications
- Vol. 35 (1) , 011201
Clinical applications of lasers in conventional periodontal care
Periodontal (gum) diseases present one of the main threats to oral and general health; they are very prevalent across the globe and, if left untreated, lead to tooth loss, with a significant impact on the quality of life. In addition, the impact of gum infection and inflammation on diabetes and cardiovascular disease complications has been well documented. Having in mind the key role of bacteria and the host’s immune response in the development of periodontal diseases but also the subgingival niche anatomy that complicates the adequate management of the dental biofilm and post-treatment healing, the field of periodontics is open to new or additional therapeutic methods that would complement the conventional approaches to periodontal care. Lasers were one of the first instruments used for photon therapy in dentistry due to their ability to emit a collimated, coherent light beam with monochromatic and synchronous wavelengths. We reviewed here the possibilities of the application and therapeutic effects of lasers during the initial phase of periodontal therapy using Er:YAG, Nd:YAG, CO2, and diode lasers. Therefore, the aim of this paper is to summarize the use of lasers and their clinical effects as adjuncts to the conventional, nonsurgical treatment of patients with periodontitis and to facilitate a scientific debate on this under-researched and controversial field of dental care.
- 26 January 2023
- Published by Laser Institute of America in Journal of Laser Applications
- Vol. 35 (1) , 011201
Open AccessClinical applications of lasers in conventional periodontal care
Periodontal (gum) diseases present one of the main threats to oral and general health; they are very prevalent across the globe and, if left untreated, lead to tooth loss, with a significant impact on the quality of life. In addition, the impact of gum infection and inflammation on diabetes and cardiovascular disease complications has been well documented. Having in mind the key role of bacteria and the host’s immune response in the development of periodontal diseases but also the subgingival niche anatomy that complicates the adequate management of the dental biofilm and post-treatment healing, the field of periodontics is open to new or additional therapeutic methods that would complement the conventional approaches to periodontal care. Lasers were one of the first instruments used for photon therapy in dentistry due to their ability to emit a collimated, coherent light beam with monochromatic and synchronous wavelengths. We reviewed here the possibilities of the application and therapeutic effects of lasers during the initial phase of periodontal therapy using Er:YAG, Nd:YAG, CO2, and diode lasers. Therefore, the aim of this paper is to summarize the use of lasers and their clinical effects as adjuncts to the conventional, nonsurgical treatment of patients with periodontitis and to facilitate a scientific debate on this under-researched and controversial field of dental care.
- Open Access
- 1 January 2022
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 150 (5-6) , 267-273
Comparison of bromazepam and ibuprofen influence on tooth pulp-evoked potentials in humans
Introduction/Objective. Somatosensory evoked potentials are a neurophysiological tool for testing the effects of drugs in humans and animals. The aim of this study was to estimate the way that bromazepam and ibuprofen had on tooth pulp-evoked potentials (TPEPs) after non-painful stimuli, as well as to detect possible differences in this activity. Methods. Sixty young healthy subjects were included in the study. They were arranged into three groups: ibuprofen, bromazepam, and placebo. To record TPEPs response, dental pulp were electrically stimulated through intact enamel with non-painful stimuli. For stimulation and registration we used Xltek Protektor 32 system, software EPWorks, version 5.0 (Natus Medical Incorporated, Oakville, ON, Canada). The experiment consisted of two testing sessions. Five recordings were performed in each session. The first test session was before, and the second was 45 minutes after administration of a single dose of the ibuprofen (400 mg), bromazepam (1.5 mg) or placebo. Results. The results of the present study exhibit that both ibuprofen and bromazepam significantly increased all the latencies; ibuprofen decreased amplitudes of all the waves except the first one (p < 0.05), and bromazepam decreased amplitudes of all the waves except the first one (p < 0.05); placebo did not modified TPEPs waves (p > 0.05). Additionally, there were no significant differences in influence on TPEPs between bromazepam and ibuprofen (p > 0.05). Conclusion. Our study showed that both bromazepam and ibuprofen had the same influence on TPEPs after non-painful stimuli. That indicates that anxiolytic dose of bromazepam affects neurotransmission in the same manner as non-opioid analgesics ibuprofen.
- 1 January 2022
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 150 (5-6) , 267-273
Open AccessComparison of bromazepam and ibuprofen influence on tooth pulp-evoked potentials in humans
Introduction/Objective. Somatosensory evoked potentials are a neurophysiological tool for testing the effects of drugs in humans and animals. The aim of this study was to estimate the way that bromazepam and ibuprofen had on tooth pulp-evoked potentials (TPEPs) after non-painful stimuli, as well as to detect possible differences in this activity. Methods. Sixty young healthy subjects were included in the study. They were arranged into three groups: ibuprofen, bromazepam, and placebo. To record TPEPs response, dental pulp were electrically stimulated through intact enamel with non-painful stimuli. For stimulation and registration we used Xltek Protektor 32 system, software EPWorks, version 5.0 (Natus Medical Incorporated, Oakville, ON, Canada). The experiment consisted of two testing sessions. Five recordings were performed in each session. The first test session was before, and the second was 45 minutes after administration of a single dose of the ibuprofen (400 mg), bromazepam (1.5 mg) or placebo. Results. The results of the present study exhibit that both ibuprofen and bromazepam significantly increased all the latencies; ibuprofen decreased amplitudes of all the waves except the first one (p < 0.05), and bromazepam decreased amplitudes of all the waves except the first one (p < 0.05); placebo did not modified TPEPs waves (p > 0.05). Additionally, there were no significant differences in influence on TPEPs between bromazepam and ibuprofen (p > 0.05). Conclusion. Our study showed that both bromazepam and ibuprofen had the same influence on TPEPs after non-painful stimuli. That indicates that anxiolytic dose of bromazepam affects neurotransmission in the same manner as non-opioid analgesics ibuprofen.